MM-897: Efficacy of Isatuximab Plus Dexamethasone Versus No Isatuximab-Based Treatments in Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Simple item page
dc.contributor.authorVíctor Castillo
dc.contributor.authorLuis E. Cueva-Cañola
dc.contributor.authorAlex Torres
dc.contributor.authorA. Pérez
dc.contributor.authorAlejandro Muñóz
dc.contributor.authorAbraham Zenteno-Aguilar
dc.contributor.authorKaroly P Zuñiga-Montaño
dc.contributor.authorCarlos Espinosa-Temaxte
dc.contributor.authorSergio Morales Acosta
dc.contributor.authorWagner Rios-Acosta
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:05:18Z
dc.date.available2026-03-22T21:05:18Z
dc.date.issued2025
dc.descriptionCitaciones: 1
dc.identifier.doi10.1016/s2152-2650(25)02654-0
dc.identifier.urihttps://doi.org/10.1016/s2152-2650(25)02654-0
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85856
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemia
dc.sourceUniversidad Autónoma de Baja California
dc.subjectMedicine
dc.subjectMeta-analysis
dc.subjectDexamethasone
dc.subjectMultiple myeloma
dc.subjectInternal medicine
dc.titleMM-897: Efficacy of Isatuximab Plus Dexamethasone Versus No Isatuximab-Based Treatments in Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
dc.typereview

Files

Collections

Artículo Científico Publicado